Postbiotics are a byproduct of the prebiotic and probiotic digestion process. Enzymes, short-fatty acids and bacterial lysates are some examples of postbiotics.
Demand for this product category is growing mainly because early research has suggested that postbiotics may provide a number of potential health benefits, including:
- Reducing allergy symptoms
- Relieving constipation and diarrhea
- Treating colic symptoms
Postbiotic supplements are not yet widely available. But we are seeing a growing selection of postbiotics being sold, primarily via DTC.
For example, one popular pack of postbiotics generates around $60K/month on Amazon.
Postbiotics are part of the Microbiome Therapeutics meta trend.
The number of microbiome therapeutics studies published last year increased by 15%, suggesting that the space is getting more attention.
This is leading to more microbiome supplement launches. The Mintel database estimates that microbiome product launches increased by approximately 17% last year.
And it’s looking like this space has plenty of future growth — the market for microbiome therapeutics is expected to increase 8x in the next four years.
Synbiotics and prebiotics are examples of trending microbiome therapeutics.